---
title: "Postoperative C-Reactive Protein Predicts Delirium Incidence and Severity in Older Surgical Patien"
id: "medrxiv-7-the-association-of-c-reactive-protein-with-delirium-severity-an-analysis-of-a"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-7-the-association-of-c-reactive-protein-with-delirium-severity-an-analysis-of-a"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.22.26366074v1?rss=1"
published_at: "2026-10-23T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Postoperative C-Reactive Protein Predicts Delirium Incidence and Severity in Older Surgical Patien
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-7-the-association-of-c-reactive-protein-with-delirium-severity-an-analysis-of-a
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.22.26366074v1?rss=1)
- **Published At:** 2026-10-23T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Prospective cohort of 122 patients aged ≥60 undergoing major surgery; investigators measured **C-reactive protein** (CRP) preoperatively and on postoperative day 1. - Delirium surveillance used the **3D-CAM** twice daily on postoperative days 1–3; outcomes were delirium incidence (any positive 3D-CAM) and peak delirium severity (maximum 3D-CAM score). - Postoperative delirium (POD) occurred in 20 of 122 patients (16.4%); mean peak severity score was 2.1 (SD 2.1). - Data indicated a strong association between elevated postoperative CRP and both higher **POD incidence** and greater **POD severity**; investigators report high predicted probabilities for these associations. - The cohort analysis found that anti-emetic doses of **dexamethasone** were associated with a 41% reduction in CRP (95% CrI 8–62%), and the study team reported a high predicted probability for that effect. - The authors concluded routine postoperative CRP was independently associated with delirium outcomes and suggested that trials targeting inflammation to prevent delirium are supported by these findings. - The paper states ethical approval and consent procedures were completed; data availability is conditional on ethics. The source did not report specific dexamethasone dosing details or detailed multivariable model covariates in the abstract, and those methodological specifics were not available in the provided source text.
## Clinical Analysis & Structured Key Points
The association of C-Reactive Protein with Delirium Severity: An analysis of a prospective cohort study | medRxiv Skip to main content The association of C-Reactive Protein with Delirium Severity: An analysis of a prospective cohort study Fiona Schnitzler , Kaitlin Kramer , Samantha Curtis , Belinda Anderson , Kyriakos Matsis , Amy Lawrence , Gerald Wong , Ben Moran , Neil Pillinger , Robert Sanders doi: https://doi.org/10.64898/2026.10.22.26366074 Fiona Schnitzler 1 Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: fiona.schnitzler{at}sydney.edu.au Kaitlin Kramer 1 Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Samantha Curtis 2 Department of Anaesthetics, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Belinda Anderson 2 Department of Anaesthetics, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kyriakos Matsis 2 Department of Anaesthetics, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Amy Lawrence 2 Department of Anaesthetics, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Gerald Wong 2 Department of Anaesthetics, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ben Moran 3 Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. Find this author on Google Scholar Find this author on PubMed Search for this author on this site Neil Pillinger 1 Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Robert Sanders 1 Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Postoperative delirium (POD) is common in elderly patients and is linked to poor recovery and greater mortality. Inflammation has been implicated in its pathophysiology and recent meta-analysis suggests steroids may have utility in preventing POD. This study aimed to evaluate whether C-reactive protein (CRP) predicts severity (or incidence) of POD. Our secondary outcome analysed whether anti-emetic doses of dexamethasone meaningfully altered inflammatory responses in this age group. Patients (n=122) ≥60 years of age undergoing major surgery were recruited to a prospective cohort study in which CRP was measured preoperatively and on postoperative day 1. Delirium was assessed using the 3-minute diagnostic Confusion Assessment Method (3D-CAM) twice daily on days 1–3. CRP was analysed against the outcomes of incidence (positive overall 3D-CAM) and peak severity (maximum 3D-CAM score) of POD. POD occurred in 20/122 (16.4%); mean peak severity 2.1 (SD 2.1). Postoperative CRP was associated with the primary outcome, POD severity (predicted probability 94.7%) as well as incidence (predicted probability 99.9%). Dexamethasone reduced CRP by 41% (95% CrI 8-62%, predicted probability 99.1%). Routine postoperative CRP was independently associated with POD incidence and severity. Dexamethasone, at anti-emetic doses, was associated with a substantial reduction in CRP levels, supporting trials focussed on modulating inflammation to prevent delirium. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Sydney Local Health District Ethics Committee for Royal Prince Alfred Hospital gave ethical approval for this work in June 2023 (Protocol No. X23-0165 & 2023/ETH00923). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Data may be available on request if consistent with ethics guidance. Funder Information Declared ANZCA Foundation Grant , 26/014 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted October 23, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following The association of C-Reactive Protein with Delirium Severity: An analysis of a prospective cohort study Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share The association of C-Reactive Protein with Delirium Severity: An analysis of a prospective cohort study Fiona Schnitzler , Kaitlin Kramer , Samantha Curtis , Belinda Anderson , Kyriakos Matsis , Amy Lawrence , Gerald Wong , Ben Moran , Neil Pillinger , Robert Sanders medRxiv 2026.10.22.26366074; doi: https://doi.org/10.64898/2026.10.22.26366074 Share This Article: Copy Citation Tools The association of C-Reactive Protein with Delirium Severity: An analysis of a prospective cohort study Fiona Schnitzler , Kaitlin Kramer , Samantha Curtis , Belinda Anderson , Kyriakos Matsis , Amy Lawrence , Gerald Wong , Ben Moran , Neil Pillinger , Robert Sanders medRxiv 2026.10.22.26366074; doi: https://doi.org/10.64898/2026.10.22.26366074 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (634) Allergy and Immunology (914) Anesthesia (346) Cardiovascular Medicine (4943) Dentistry and Oral Medicine (490) Dermatology (425) Emergency Medicine (672) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1667) Epidemiology (16164) Forensic Medicine (35) Gastroenterology (1236) Genetic and Genomic Medicine (7213) Geriatric Medicine (747) Health Economics (1091) Health Informatics (5222) Health Policy (1456) Health Systems and Quality Improvement (1812) Hematology (597) HIV/AIDS (1370) Infectious Diseases (except HIV/AIDS) (16427) Intensive Care and Critical Care Medicine (1192) Medical Education (690) Medical Ethics (156) Nephrology (739) Neurology (7499) Nursing (375) Nutrition (1114) Obstetrics and Gynecology (1281) Occupational and Environmental Health (1031) Oncology (3708) Ophthalmology (1079) Orthopedics (401) Otolaryngology (462) Pain Medicine (493) Palliative Medicine (142) Pathology (717) Pediatrics (1844) Pharmacology and Therapeutics (749) Primary Care Research (781) Psychiatry and Clinical Psychology (6065) Public and Global Health (9915) Radiology and Imaging (2499) Rehabilitation Medicine and Physical Therapy (1500) Respiratory Medicine (1263) Rheumatology (655) Sexual and Reproductive Health (794) Sports Medicine (594) Surgery (795) Toxicology (109) Transplantation (315) Urology (303)
## Related Clinical Research

- [Cardiometabolic risk across post-DST cortisol levels in adrenal incidentaloma patients](https://medichelpline.com/clinical-feed/pubmed-42804108.md) (DOI: 10.1007/s12020-026-04794-2)
- [Size-Dependent Anti-Inflammatory Nanocarriers Reduce Body Weight and Fat Without Suppressing Food](https://medichelpline.com/clinical-feed/pubmed-42708907.md) (DOI: 10.1021/acsnano.6c00432)
- [Surgical-name Embeddings Using Large Language Models for Confounding Adjustment in Perioperative O](https://medichelpline.com/clinical-feed/medrxiv-14-large-language-model-embeddings-of-surgical-procedural-names-for-confounding.md)
- [FDA approves Zenbexus (iberdomide) for multiple myeloma, first of a novel drug class](https://medichelpline.com/clinical-feed/stat-news-1-stat-fda-approves-bristol-multiple-myeloma-treatment-marking-debut-of-novel.md)
- [Coexisting AL (λ) amyloidosis and POEMS syndrome presenting as refractory heart failure: a case re](https://medichelpline.com/clinical-feed/frontiers-in-immunology-8-a-rare-coexistence-of-immunoglobulin-light-chain-amyloidosis-and-poems-syndrome.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.